In the next several months, DS Laboratories expects to roll out its leave-in hair-growth treatments, both with and without minoxidil.
Divine Skin's Brazilian strategy targets a rapidly expanding and ethnically diverse market of 201 million people, the fifth most populous country in the world.
One of the first emerging markets to recover after the recent downturn, Brazil's economy exceeds all other Latin American countries. It has a gross domestic product of $2 trillion (No. 10 in the world), median age of just 28.9 years, life expectancy of 72 years, and population growth rate of 1.2 percent per year.
By establishing new sales operations in Brazil, Divine Skin expects to minimize bureaucratic demands by the drug-control agency, Anvisa.About Divine Skin Divine Skin Inc. develops, markets, and distributes personal-care products through cosmetics wholesalers, online retailers, specialty outlets, spas, salons, and medical offices in more than 20 countries. Its brands include DS Laboratories, Sigma Skin, and Polaris Research. DS Laboratories, the flagship brand, offers high-performance topical solutions for men and women to restore growth and radiance to hair; suppress dandruff and unwanted hair; control acne; maintain feminine hygiene; and reduce the appearance of cellulite, wrinkles, and double chins ( www.dslaboratories.com). The Sigma Skin brand targets men and sells through upscale retailers like Bergdorf Goodman and Neiman Marcus in the United States, Saks Fifth Avenue in Mexico, and Harvey Nichols in the United Kingdom. Products are designed to reverse hair loss and other signs of aging ( www.sigmaskin.com). Polaris Research makes high-potency minoxidil-based hair-growth formulas ( www.polarisresearch.co.uk). Divine Skin's management believes the company has established itself as a leader in topical therapies, especially hair-growth, through aggressive pursuit of innovation and technology. Products employ comprehensive formulas with multiple methods of action against common skin conditions.